IEEE UFFC Seattle Tech Talk - Ultrasound and Microbubbles for Anticancer Drug Delivery (June 25)
The Seattle Chapter of the IEEE Ultrasonics, Ferroelectrics, and Frequency Control Society (UFFC-S) aims to provide UFFC-S members with opportunities for professional and personal growth as well as network with the local, vibrant UFFC community.
Dr. Ayache Bouakaz, PhD will be our guest speaker. Dr. Bouakaz is Director of Research at the Imaging & Brain Institute of the Institut National de la Santé et de la Recherche Médicale (INSERM) in Tours, France. His research focuses on imaging and therapeutic applications of ultrasound. He is a prolific author and inventor. He is notably the IEEE UFFC Distinguished Lecturer for 2023-2024.
Dr. Bouakaz will present on "Ultrasound and microbubbles for anticancer drug delivery: From physics to clinics."
This meeting will be co-sponsored by the University of Washington in Seattle and the IEEE UFFC Seattle Chapter. The University of Washington will host this event. Please register so that organizers can plan accordingly.
NOTE: Dr. Bouakaz will be in the Seattle area for two nights. On June 24th he will present at Philips Healthcare in Bothell. On June 25th he will present at the University of Washington in Seattle. Feel free to attend either or both events.
Date and Time
Location
Hosts
Registration
- Date: 25 Jun 2024
- Time: 10:00 PM UTC to 11:30 PM UTC
-
Add Event to Calendar
- University of Washington
- 3720 15th Ave NE
- Seattle, Washington
- United States 98105
- Building: William H. Foege Hall
- Room Number: N130
- Click here for Map
- Contact Event Hosts
- Co-sponsored by University of Washington
- Starts 24 May 2024 07:00 AM UTC
- Ends 26 June 2024 02:30 AM UTC
- No Admission Charge
Speakers
Ayache
Ultrasound and microbubbles for anticancer drug delivery: From physics to clinics
Ultrasound, in conjunction with microbubbles, offers a promising drug delivery method. This approach, known as sonoporation, enables targeted drug delivery by temporarily permeating biological barriers (e.g., cell membrane, vessel wall) under ultrasound insonation. It shows potential for a wide range of therapeutic agents, including chemotherapeutics, nucleic acids, peptides, and antibodies. While preclinical studies have demonstrated promise, several challenges must be addressed for clinical translation. These include standardizing ultrasound parameters, selecting suitable microbubbles, identifying optimal clinical applications, and resolving questions about administration methods and treatment schedules. Additionally, the type and concentration of microbubbles, as well as their response to ultrasound activation, play critical roles. The ultimate goal is to facilitate the adoption of this technology in clinical settings, and ongoing and future trials aim to further advance drug delivery through sonoporation.
Biography:
 |
Ayache Bouakaz obtained his Master degree and his PhD in acoustics in 1992 and 1996 at the National Institute of Applied Sciences in Lyon, France (INSA Lyon). In 1998, he joined the Pennsylvania State University at State College, PA, USA as a post-doc for 2 years. From December 1999 to November 2004, he held a position of associate professor at Erasmus Medical Center in Rotterdam, the Netherlands. His research focused on ultrasound imaging, ultrasound contrast agents and transducer design.
In 2004, he obtained a position as an Inserm researcher and since 2009, he has held the position of research director in the Inserm Imaging and Brain institue, where he heads the ultrasound imaging and therapy group. His research focuses on imaging and therapeutic applications of ultrasound. Ayache Bouakaz is a "chair professor" at the Jiaotong University of Xi'an in China since 2017. He is the general chair of the international conference IEEE International Ultrasonics Symposium (IEEE IUS) 2016 in Tours, France and co-general chair of the IEEE IUS 2021. He has served as the vice-president of the IEEE UFFC society in charge of Symposia from 2017- 2020. He has published more than 214 articles in peer-reviewed journals, more than 100 articles published in conference proceedings and has filed 9 patents. |
Agenda
3:00 PM: Networking and Refreshments
3:15 PM: Welcome and Introductions
3:30 PM: Tech Talk
4:15 PM: Q&A
4:30 PM: Adjourn